AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

12,114.00p
   
  • Change Today:
    -120.00p
  • 52 Week High: 15,316.00p
  • 52 Week Low: 10,956.00p
  • Currency: UK Pounds
  • Shares Issued: 1,551.03m
  • Volume: 3,565,323
  • Market Cap: £187,892m
  • RiskGrade: 123
  • Beta: 0.00

Latest ShareCast News

Astrazeneca's Tezspire delivers positive results in EoE trial

By Iain Gilbert

Date: Thursday 27 Aug 2026

(Sharecast News) - Drugmaker AstraZeneca said on Thursday that Tezspire had delivered positive Phase III results in eosinophilic oesophagitis (EoE), hitting both co‑primary endpoints and all key secondary measures, with improvements sustained through 52 weeks.

AstraZeneca ShareCast News

AstraZeneca posts mixed lung‑cancer trial ... 17-Aug-2026 ShareCast
AstraZeneca, Bristol Myers Squibb in talks over ... 03-Aug-2026 ShareCast
AstraZeneca reports first-half growth, disappoin... 27-Jul-2026 ShareCast
AstraZeneca breast cancer drug receives EU appro... 23-Jul-2026 ShareCast
Astrazeneca strikes exclusive licensing deal wit... 14-Jul-2026 ShareCast

AstraZeneca Regulatory News

Tezspire CROSSING trial met primary endpoints 27-Aug-2026 07:00 RNS
AstraZeneca prices a €2.55 billion bond of... 25-Aug-2026 07:00 RNS
Director/PDMR Shareholding 19-Aug-2026 11:00 RNS
Enhertu improved PFS in 1L HER2m lung cancer 17-Aug-2026 07:30 RNS
Update on eVOLVE-Lung02 Phase III trial 17-Aug-2026 07:05 RNS

AstraZeneca Newspaper Links

Is now the right time to buy shares in AstraZene... 04-Aug-2026 Times
AstraZeneca shares fall on Bristol Myers Squibb ... 03-Aug-2026 Times
Fighting Frenchman shows us how as he ensures As... 30-Dec-2014 Daily Mail
Exclusive: UK firms vie for share of £170bn in A... 08-Dec-2014 The Independent
MARKET REPORT: Ariad on the up amid growing spec... 04-Dec-2014 Daily Mail

AstraZeneca Tips & Analysis

Questor :AstraZeneca 29-Apr-2014 Telegraph
Questor : AstraZeneca 24-Jan-2014 Telegraph
Questor:AstraZeneca 22-Dec-2011 Telegraph
Investment Column:AstraZeneca 28-Oct-2011 The Independent
Investment Column: AstraZeneca 23-Jun-2011 The Independent

AstraZeneca News Wires

MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire
CRESTOR Demonstrates Dramatic CV Risk Reduction ... 09-Nov-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 12,114.00p
Change Today -120.00p
% Change -0.98 %
52 Week High 15,316.00p
52 Week Low 10,956.00p
Volume 3,565,323
Shares Issued 1,551.03m
Market Cap £187,892m
Beta 0.00
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 5
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 06-Aug-26 19-Feb-26
Paid 08-Sep-26 23-Mar-26
Amount 106.00¢ 217.00¢

Trades for 27-Aug-2026

Time Volume / Share Price
13:13 300,210 @ 12,194.00p
13:13 300,210 @ 12,194.00p
16:53 161 @ 12,114.00p
16:53 132 @ 12,114.00p
16:37 54,000 @ 12,118.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page